JF Standing (1,2), RF Howard (1,3), A Johnston (4), I Savage (2), ICK Wong (1,2,3) Developmental Pharmacokinetics of Diclofenac for Acute Pain
|
Strougo, A(1), Elassaiss-Schaap, J(2), de Greef, HJMM(2), Drenth, H(1) Mechanism-based model of the effect of co-administration of exogenous testosterone and progestogens on the hypothalamic-pituitary-gonodal axis in men
|
Teun Post(1), Tomoo Funaki(2), Hiromi Maune(2), Henk-Jan Drenth(1) Circadian rhythm in pharmacodynamics and its influence on the identification of treatment effects
|
Dartois C, Looby M, He H, Steimer J-L, and Pillai G. Impact of handling missing PK data on PD estimation – explicit modeling of BLQ data in WinBUGS® reduced bias in the PD predictions - a preclinical example.
|
Tim Sheiner Planning To Communicate
|
Benoit You (1,2) , Paul Perrin (1,2), Philippe Paparel (1,2), Gilles Freyer (1,2), Olivier Colomban (1) Brigitte Tranchand (1,3), Pascal Girard (1) Kinetic models of PSA decrease after surgery in prostate tumor diseases as a help for clinician interpretation
|
Kim Stuyckens, Stefaan Rossenu, Peter King, Janine Arts, Juan Jose Perez-Ruixo. Modeling Drug Effects and Resistance Development on Tumor Growth Dynamics
|
Kristin E. Karlsson(1), Justin Wilkins(1,3), Mats O. Karlsson(1) and E. Niclas Jonsson(1,2) Modelling of disease progression in acute stroke by simultaneously using the NIH stroke scale, the Scandinavian stroke scale and the Barthel index
|
Philippe Jacqmin (1), Lynn McFadyen (2) and Janet R. Wade (1) Basic PK/PD principles of proliferative and circular systems
|
E.H. Cox (1)(3), N.H. Prins (1), G. D’Souza (2) & L. McFadyen (2) Integrated Modeling & Simulation of Clinical Response and Drop-out of D2 receptor agonists in Patients with Early Parkinson’s Disease.
|
Claudio Cobelli Models of Glucose Metabolism and Control in Diabetes
|